Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 5 of 5 entries
Sorted by: Best Match Show Resources per page
Consecutive lynestrenol and cross-sex hormone treatment in biological female adolescents with gender dysphoria: a retrospective analysis.

Biology of sex differences

Tack LJ, Craen M, Dhondt K, Vanden Bossche H, Laridaen J, Cools M.
PMID: 26885361
Biol Sex Differ. 2016 Feb 16;7:14. doi: 10.1186/s13293-016-0067-9. eCollection 2016.

BACKGROUND: Prior to the start of cross-sex hormone therapy (CSH), androgenic progestins are often used to induce amenorrhea in female to male (FtM) pubertal adolescents with gender dysphoria (GD). The aim of this single-center study is to report changes...

Cite
Tack LJ, Craen M, Dhondt K, et al. Consecutive lynestrenol and cross-sex hormone treatment in biological female adolescents with gender dysphoria: a retrospective analysis. Biol Sex Differ. 2016;7:14doi: 10.1186/s13293-016-0067-9.
Tack, L. J., Craen, M., Dhondt, K., Vanden Bossche, H., Laridaen, J., & Cools, M. (2016). Consecutive lynestrenol and cross-sex hormone treatment in biological female adolescents with gender dysphoria: a retrospective analysis. Biology of sex differences, 714. https://doi.org/10.1186/s13293-016-0067-9
Tack, Lloyd J W, et al. "Consecutive lynestrenol and cross-sex hormone treatment in biological female adolescents with gender dysphoria: a retrospective analysis." Biology of sex differences vol. 7 (2016): 14. doi: https://doi.org/10.1186/s13293-016-0067-9
Tack LJ, Craen M, Dhondt K, Vanden Bossche H, Laridaen J, Cools M. Consecutive lynestrenol and cross-sex hormone treatment in biological female adolescents with gender dysphoria: a retrospective analysis. Biol Sex Differ. 2016 Feb 16;7:14. doi: 10.1186/s13293-016-0067-9. eCollection 2016. PMID: 26885361; PMCID: PMC4754845.
Copy Download .nbib Format: NLM
Diversity-oriented synthesis of 17-spirosteroids.

Beilstein journal of organic chemistry

Laroche B, Bouvarel T, Louis-Sylvestre M, Nay B.
PMID: 32461769
Beilstein J Org Chem. 2020 Apr 28;16:880-887. doi: 10.3762/bjoc.16.79. eCollection 2020.

A diversity-oriented synthesis (DOS) approach has been used to functionalize 17-ethynyl-17-hydroxysteroids through a one-pot procedure involving a ring-closing enyne metathesis (RCEYM) and a Diels-Alder reaction on the resulting diene, under microwave irradiations. Taking advantage of the propargyl alcohol moiety...

Cite
Laroche B, Bouvarel T, Louis-Sylvestre M, et al. Diversity-oriented synthesis of 17-spirosteroids. Beilstein J Org Chem. 2020;16:880-887doi: 10.3762/bjoc.16.79.
Laroche, B., Bouvarel, T., Louis-Sylvestre, M., & Nay, B. (2020). Diversity-oriented synthesis of 17-spirosteroids. Beilstein journal of organic chemistry, 16880-887. https://doi.org/10.3762/bjoc.16.79
Laroche, Benjamin, et al. "Diversity-oriented synthesis of 17-spirosteroids." Beilstein journal of organic chemistry vol. 16 (2020): 880-887. doi: https://doi.org/10.3762/bjoc.16.79
Laroche B, Bouvarel T, Louis-Sylvestre M, Nay B. Diversity-oriented synthesis of 17-spirosteroids. Beilstein J Org Chem. 2020 Apr 28;16:880-887. doi: 10.3762/bjoc.16.79. eCollection 2020. PMID: 32461769; PMCID: PMC7214869.
Copy Download .nbib Format: NLM
Positive association between progestins and the evolution of multiple fibroadenomas in 72 women.

Endocrine connections

Grouthier V, Chakhtoura Z, Tejedor I, Badachi Y, Goffin V, Touraine P.
PMID: 32485673
Endocr Connect. 2020 Jun;9(6):570-577. doi: 10.1530/EC-20-0012.

OBJECTIVE: Multiple fibroadenomas (MFA) of the breast is a rare benign disease, thus its natural history is poorly understood. The aim of our study was to describe the radiological evolution of MFA and to evaluate the influence of different...

Cite
Grouthier V, Chakhtoura Z, Tejedor I, et al. Positive association between progestins and the evolution of multiple fibroadenomas in 72 women. Endocr Connect. 2020;9(6):570-577doi: 10.1530/EC-20-0012.
Grouthier, V., Chakhtoura, Z., Tejedor, I., Badachi, Y., Goffin, V., & Touraine, P. (2020). Positive association between progestins and the evolution of multiple fibroadenomas in 72 women. Endocrine connections, 9(6), 570-577. https://doi.org/10.1530/EC-20-0012
Grouthier, Virginie, et al. "Positive association between progestins and the evolution of multiple fibroadenomas in 72 women." Endocrine connections vol. 9,6 (2020): 570-577. doi: https://doi.org/10.1530/EC-20-0012
Grouthier V, Chakhtoura Z, Tejedor I, Badachi Y, Goffin V, Touraine P. Positive association between progestins and the evolution of multiple fibroadenomas in 72 women. Endocr Connect. 2020 Jun;9(6):570-577. doi: 10.1530/EC-20-0012. PMID: 32485673; PMCID: PMC7354733.
Copy Download .nbib Format: NLM
The cost-effective, but forgotten, medical endometriosis therapy: a prospective, quasi-randomized study on progestin therapy.

Facts, views & vision in ObGyn

Cezar TC, Schweppe KW, Pletzer KR, Becker S, Krentel H, Torres-De La Roche LA, De Wilde RL.
PMID: 31367290
Facts Views Vis Obgyn. 2018 Dec;10(4):181-190.

Endometriosis represents nowadays a real burden for the patients as well as for the physicians, as it requires surgical and/or medical treatment, often long - termed and repeated. Moreover, the high costs necessary to diagnose and treat endometriosis represent...

Cite
Cezar TC, Schweppe KW, Pletzer KR, et al. The cost-effective, but forgotten, medical endometriosis therapy: a prospective, quasi-randomized study on progestin therapy. Facts Views Vis Obgyn. 2018;10(4):181-190
Cezar, T. C., Schweppe, K. W., Pletzer, K. R., Becker, S., Krentel, H., Torres-De La Roche, L. A., & De Wilde, R. L. (2018). The cost-effective, but forgotten, medical endometriosis therapy: a prospective, quasi-randomized study on progestin therapy. Facts, views & vision in ObGyn, 10(4), 181-190.
Cezar, T C, et al. "The cost-effective, but forgotten, medical endometriosis therapy: a prospective, quasi-randomized study on progestin therapy." Facts, views & vision in ObGyn vol. 10,4 (2018): 181-190.
Cezar TC, Schweppe KW, Pletzer KR, Becker S, Krentel H, Torres-De La Roche LA, De Wilde RL. The cost-effective, but forgotten, medical endometriosis therapy: a prospective, quasi-randomized study on progestin therapy. Facts Views Vis Obgyn. 2018 Dec;10(4):181-190. PMID: 31367290; PMCID: PMC6658201.
Copy Download .nbib Format: NLM
Classification and pharmacology of progestins.

Maturitas

Schindler AE, Campagnoli C, Druckmann R, Huber J, Pasqualini JR, Schweppe KW, Thijssen JH.
PMID: 19434889
Maturitas. 2008 Sep-Oct;61(1):171-80. doi: 10.1016/j.maturitas.2008.11.013.

Besides the natural progestin, progesterone, there are different classes of progestins, such as retroprogesterone (i.e. dydrogesterone), progesterone derivatives (i.e. medrogestone) 17alpha-hydroxyprogesterone derivatives (i.e. chlormadinone acetate, cyproterone acetate, medroxyprogesterone acetate, megestrol acetate), 19-norprogesterone derivatives (i.e. nomegestrol, promegestone, trimegestone, nesterone), 19-nortestosterone...

Cite
Schindler AE, Campagnoli C, Druckmann R, et al. Classification and pharmacology of progestins. Maturitas. 2008;61(1):171-80doi: 10.1016/j.maturitas.2008.11.013.
Schindler, A. E., Campagnoli, C., Druckmann, R., Huber, J., Pasqualini, J. R., Schweppe, K. W., & Thijssen, J. H. (2008). Classification and pharmacology of progestins. Maturitas, 61(1), 171-80. https://doi.org/10.1016/j.maturitas.2008.11.013
Schindler, Adolf E, et al. "Classification and pharmacology of progestins." Maturitas vol. 61,1 (2008): 171-80. doi: https://doi.org/10.1016/j.maturitas.2008.11.013
Schindler AE, Campagnoli C, Druckmann R, Huber J, Pasqualini JR, Schweppe KW, Thijssen JH. Classification and pharmacology of progestins. Maturitas. 2008 Sep-Oct;61(1):171-80. doi: 10.1016/j.maturitas.2008.11.013. PMID: 19434889.
Copy Download .nbib Format: NLM
Showing 1 to 5 of 5 entries